BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19509066)

  • 1. Impact of connexin32 deletion on E7 or RET/PTC3 oncogene-driven growth and neoplastic transformation of the thyroid gland.
    Prost G; Bernier-Valentin F; Croset M; Rousset B
    Endocr Relat Cancer; 2009 Sep; 16(3):873-84. PubMed ID: 19509066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connexin-32 acts as a downregulator of growth of thyroid gland.
    Prost G; Bernier-Valentin F; Munari-Silem Y; Selmi-Ruby S; Rousset B
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E291-9. PubMed ID: 18042666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.
    Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B
    Endocrinology; 2008 Oct; 149(10):5107-17. PubMed ID: 18583418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.
    Jin L; Burniat A; Dumont JE; Miot F; Corvilain B; Franc B
    Br J Cancer; 2008 Dec; 99(11):1874-83. PubMed ID: 18985036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological changes induced by selective inactivation of menin on the thyroid gland in RET÷PTC3 and E7 transgenic mice. A study of 77 cases.
    Căpraru OM; Berger N; Gadot N; Decaussin-Petrucci M; Zhang C; Borda A; Szilágyi T; Borson-Chazot F; Selmi-Ruby S
    Rom J Morphol Embryol; 2016; 57(1):91-8. PubMed ID: 27151693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice.
    Portella G; Borselli C; Santoro M; Gerbasio D; D'Armiento MR; Dumont JE; Ledent C; Rothstein JL; Vecchio G; Fusco A
    Oncol Res; 2001; 12(8):347-54. PubMed ID: 11589306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells.
    Shinohara S; Rothstein JL
    Oncogene; 2004 Sep; 23(45):7571-9. PubMed ID: 15326486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
    Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of connexin 32 in steady-state hematopoiesis, regeneration state, and leukemogenesis.
    Hirabayashi Y; Yoon BI; Tsuboi I; Huo Y; Kodama Y; Kanno J; Ott T; Trosko JE; Inoue T
    Exp Biol Med (Maywood); 2007 May; 232(5):700-12. PubMed ID: 17463168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncoprotein signaling mediates tumor-specific inflammation and enhances tumor progression.
    Pufnock JS; Rothstein JL
    J Immunol; 2009 May; 182(9):5498-506. PubMed ID: 19380798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
    Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
    Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
    Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
    Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.
    Coppée F; Gérard AC; Denef JF; Ledent C; Vassart G; Dumont JE; Parmentier M
    Oncogene; 1996 Oct; 13(7):1471-82. PubMed ID: 8875985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice.
    Moennikes O; Stahl S; Bannasch P; Buchmann A; Schwarz M
    Carcinogenesis; 2003 Sep; 24(9):1561-5. PubMed ID: 12819187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid cell proliferation in response to forced expression of gap junction proteins.
    Flachon V; Tonoli H; Selmi-Ruby S; Durand C; Rabilloud R; Rousset B; Munari-Silem Y
    Eur J Cell Biol; 2002 May; 81(5):243-52. PubMed ID: 12067060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.
    Buckwalter TL; Venkateswaran A; Lavender M; La Perle KM; Cho JY; Robinson ML; Jhiang SM
    Oncogene; 2002 Nov; 21(53):8166-72. PubMed ID: 12444552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.
    Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM
    Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of three-dimensional thyroid follicle-like structures by polarized FRT cells made communication competent by transfection and stable expression of the connexin-32 gene.
    Tonoli H; Flachon V; Audebet C; Callé A; Jarry-Guichard T; Statuto M; Rousset B; Munari-Silem Y
    Endocrinology; 2000 Apr; 141(4):1403-13. PubMed ID: 10746644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory mediators and genetic background in oncogene mediated tumor progression.
    Russell JP; Engiles JB; Rothstein JL
    J Immunol; 2004 Apr; 172(7):4059-67. PubMed ID: 15034017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
    Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.